Assessment of therapy response in malignant tumours with 18F-fluorothymidine
Author:
- 4 May 2007
- journal article
- editorial
- Published by Springer Nature in European Journal of Nuclear Medicine and Molecular Imaging
- Vol. 34 (9) , 1334-1338
Abstract
No abstract availableThis publication has 25 references indexed in Scilit:
- Imaging early changes in proliferation at 1 week post chemotherapy: a pilot study in breast cancer patients with 3′-deoxy-3′-[18F]fluorothymidine positron emission tomographyEuropean Journal of Nuclear Medicine and Molecular Imaging, 2007
- Are We Taking Without Giving in Return? The Ethics of Research-Related Biopsies and the Benefits of Clinical Trial ParticipationJournal of Clinical Oncology, 2006
- Usefulness of 3′-[F-18]Fluoro-3′-deoxythymidine with Positron Emission Tomography in Predicting Breast Cancer Response to TherapyMolecular Imaging and Biology, 2005
- Quantification of Cellular Proliferation in Tumor and Normal Tissues of Patients with Breast Cancer by [18F]Fluorothymidine-Positron Emission Tomography Imaging: Evaluation of Analytical MethodsCancer Research, 2005
- Early Detection of Tumor Response to Chemotherapy by 3′-Deoxy-3′-[18F]Fluorothymidine Positron Emission Tomography: The Effect of Cisplatin on a Fibrosarcoma Tumor Model In vivoCancer Research, 2005
- Utility of fluorodeoxyglucose-PET imaging in the management of patients with Hodgkin's and non-Hodgkin's lymphomasRadiologic Clinics of North America, 2004
- The uptake of 3?-deoxy-3?-[18F]fluorothymidine into L5178Y tumours in vivo is dependent on thymidine kinase 1 protein levelsEuropean Journal of Nuclear Medicine and Molecular Imaging, 2004
- The role of functional and molecular imaging in cancer drug discovery and developmentBritish Journal of Radiology, 2003
- New Guidelines to Evaluate the Response to Treatment in Solid TumorsJNCI: Journal of the National Cancer Institute, 2000
- Imaging proliferation in vivo with [F-18]FLT and positron emission tomographyNature Medicine, 1998